CRISPR is a part of DNA sequences found within the genomes.The technologies allow genetic material to be modified readily like adding, cutt...
It’s time to get real about CRISPR demanded, Feng Zhang a Chinese-American biochemist a professor in Neuroscience at Massachusetts Institute of Technology (MIT) “There are really exciting advances in three areas. The first area is CRISPR-based medicine. Some clinical trials are already underway and drug developers are now testing CRISPR in the context of blood diseases, like sickle cell, and also testing it in the eye to treat blindness. There is also work that’s moving quite quickly to apply CRISPR in cancer treatments. “The second area is turning CRISPR into a robust diagnostic tool for infectious diseases like Ebola, or any sort of epidemic virus, and also advancing its application in the future for diagnosing bacterial infections or maybe even cancer. “And the third area is the ability of gene editing to improve agriculture. Making farming more efficient, being able to increase the crop yield, and being able to increase the nutritional properties of agricultural produce to be able to vastly improve human health. And you know, CRISPR-based diagnostics could be used for food safety as well — being able to see if a certain food is contaminated by certain bacteria.
“My hope is that society as a whole will begin to engage in a serious conversation about what is the objective, in terms of gene editing and changing the human germline. The news that came out of China is catalyzing that conversation. It’s an important conversation to have, especially since the technology is so imminent. It’s important to take a pause to really have that conversation so that we can get society’s consent, in whichever direction, to figure out what we want to do — and that pause is not for CRISPR research as a whole, but specifically for the use of CRISPR in editing embryos to establish pregnancy.”
2. Artificial Intelligence (AI): Poppy Crum, chief scientist at Dolby Laboratories ''I’m looking for ways that technology enhances human capacity, and that’s very different. I think that’s critical in today’s climate. We’re entering an era where technology is bringing benefits to individuals — in their capacity, in their performance, in their success in the workplace — and generally the life will highly depend on the new directions that technology enable us. “The problem is not just bias in AI, because we’ve been talking about that for some time. It’s that we are individuals and we need to look at how a technology is going to impact different demographics. What are the behavioral changes that will happen if the technology is successful? And if it’s not? If we don’t come up with a better way of ensuring that technology is held accountable for realizing those benefits, we’re just going to end up with more demographic rifts and splits.”
3. Food Innovation: Mike Lee, founder of The Future Market “The two defining moments [in food tech in 2018] have really big implications for 2019. For one, Tyson Ventures made an investment in a company in Jerusalem called Future Meat Technologies. Tyson has a stranglehold on the traditional protein market, so it was a big signal in terms of them looking more diversely at what protein means, and looking at cellular agriculture as this viable thing of the future. I think it’ll be interesting in 2019 to see how many other Big Protein players follow suit. “The other thing is [officials in] the United States said that they would not regulate CRISPR-edited crops. There are obviously still questions about how to label it — that’s still up for debate — but the regulatory burden of introducing a CRISPR food product in the United States has become way easier. Simultaneously, Europe went the other way. They consider CRISPR to be under typical rules for genetically modified products, which are pretty stringent. I think what’s going to happen is the investment is going to move beyond the United States in a more aggressive way, and this will really going to shift the wind of innovation. For example, Calyxt has their gene-edited soybean that doesn’t produce trans fats. That’s supposed to come on the market in 2019.
 |
| Artificial neural network |
“A lot of public figures and private companies have promised a lot of things about BCIs. Like Facebook, which has promised the ability to type 100 words wireless each single minute on your phone just with your thoughts. I’m very thankful that these individuals have brought a lot of attention to BCIs, but what I fear is that the public statements may give unrealistic expectations. It’s not going to be like you have a thought of what you want for dinner and you can send it to your roommate. These devices can provide some significant function, and possibly some enhancements, to people who have neurological injury, and then possibly in some small way this will trickle down to the general public. But we all need to be responsible in how we talk about it.”
 |
| Biotech can help us stay young while growing old |
The science, the business side, the clinical trials reporting out, and the general interest from the public — all of that means that in a year from now, we may find ourselves in one of the most interesting times in human history. It always takes a long time to get a lab result to humans, usually at least a decade, but it’s coming now. There’s really no question.” David Sinclair concluded.